C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/10 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07K 7/08 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01) C07K 16/40 (2006.01) C07K 19/00 (2006.01) C12N 5/08 (2006.01) C12N 15/12 (2006.01) C12N 15/85 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2330826
This invention pertains generally to the treatment of autoimmune diseases of the central nervous system characterized by demyelination. In particular, this invention pertains to novel peptides derived from human myelin basic protein (MBP). When complexed with the appropriate major histocompatibility complex (MHC) molecule, these peptides can be used to treat multiple sclerosis and other demyelinating autoimmune diseases.
L'invention a trait de manière générale au traitement de maladies auto-immunes du système nerveux central caractérisées par une démyélinisation. En particulier, l'invention a trait à de nouveaux peptides dérivés de la protéine basique de myéline (MBP) humaine. Lorsqu'ils forment des complexes avec une molécule appropriée du complexe majeur d'histocompatibilité (CMH), ces peptides peuvent être utilisés pour traiter la sclérose en plaques et d'autres maladies auto-immunes démyélinisantes.
Arimilli Subhashini
Deshpande Shrikant
Corixa Corporation
Fetherstonhaugh & Co.
LandOfFree
Myelin basic protein peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Myelin basic protein peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myelin basic protein peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1778649